 SAN FRANCISCO, Dec. 23, 2020 GLOBE NEWSWIRE -- UC San Francisco UCSF and BridgeBio Pharma, Inc. NASDAQ: BBIO today announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients. 